secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001140361-23-022991
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bristol-Myers appoints COO and CEO-elect; shareholders elect board
------------------------------------------------------------------

- Christopher Boerner named COO effective Apr 26, 2023 and CEO effective Nov 1, 2023; elected to Board May 2, 2023.
- Shareholders elected 11 directors and approved say-on-pay compensation with 1.44B votes for.
- Deloitte & Touche ratified as auditor for 2023 with 1.77B votes for.
- Three shareholder proposals (independent chair, non-discrimination audit, special meeting) rejected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000114036123022991/0001140361-23-022991-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000114036123022991/brhc20052456_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-022991

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer